John Greene
Vermögen: 393 260 $ am 31.05.2026
Vermögen: 393 260 $ am 31.05.2026
John T. Greene ist Chief Financial Officer & Executive Vice President bei Discover Financial Services. Er ist außerdem Mitglied des Vorstands der CRISPR Therapeutics AG. Herr Greene war zuvor Chief Financial Officer der HSBC Holdings Plc und CFO-Retail Bank & Wealth Management bei HongKong & Shanghai Banking Corp. (New York) (eine Tochtergesellschaft von HSBC Holdings Plc), Chief Financial Officer-Global Business Finance bei General Electric Co., Group Chief Financial Officer für Willis Group Holdings Plc, Chief Financial Officer bei HSBC Insurance Co. of Delaware und CFO, Treasurer & Executive Vice President bei Bioverativ, Inc. Er erhielt einen MBA von der Kellogg School of Management und einen Bachelor-Abschluss von der State University of New York.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 7’000 ( 0.01% ) | 393 260 $ | 31.05.2026 | |
| 11.02.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direktor/Vorstandsmitglied | 11.06.2019 |
| NORTHROP GRUMMAN CORPORATION | Finanzdirektor/CFO | 07.01.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| DISCOVER FINANCIAL SERVICES | Finanzdirektor/CFO | 18.05.2025 |
| BIOVERATIV INC | Finanzdirektor/CFO | 01.01.2018 |
Willis Group Holdings Plc
Willis Group Holdings Plc Financial ConglomeratesFinance Operates as a holding company that through its subsidiaries provides insurance brokerage, reinsurance and consulting services | Finanzdirektor/CFO | 01.01.2016 |
HongKong & Shanghai Banking Corp. (New York)
HongKong & Shanghai Banking Corp. (New York) Regional BanksFinance Part of HSBC Holdings Plc, HongKong & Shanghai Banking Corp. (New York) is an American company. | Finanzdirektor/CFO | 01.05.2014 |
HSBC Insurance Co. of Delaware
HSBC Insurance Co. of Delaware Insurance Brokers/ServicesFinance Provides insurance services | Finanzdirektor/CFO | 01.05.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
GE Aerospace
GE Aerospace Aerospace & DefenseElectronic Technology Designs, develops, manufactures and services aircraft engines for commercial airframes & defense jet engines, avionics & power systems | Electronic Technology |
HSBC Holdings Plc
HSBC Holdings Plc Major BanksFinance Operates as a bank holding company with interest in providing national banking services | Finance |
Northrop Grumman Corp.
Northrop Grumman Corp. Aerospace & DefenseElectronic Technology Designs and manufactures space, mission, aeronautical & missile systems | Electronic Technology |
Willis Group Holdings Plc
Willis Group Holdings Plc Financial ConglomeratesFinance Operates as a holding company that through its subsidiaries provides insurance brokerage, reinsurance and consulting services | Finance |
Discover Financial Services
Discover Financial Services Finance/Rental/LeasingFinance Provides online banking, credit card, personal & home loan and online banking services | Finance |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HongKong & Shanghai Banking Corp. (New York)
HongKong & Shanghai Banking Corp. (New York) Regional BanksFinance Part of HSBC Holdings Plc, HongKong & Shanghai Banking Corp. (New York) is an American company. | Finance |
HSBC Insurance Co. of Delaware
HSBC Insurance Co. of Delaware Insurance Brokers/ServicesFinance Provides insurance services | Finance |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen